In addition, modulations of the NFκB-pathway in astrocytes have proven unsuccessful in slowing down disease progression, suggesting that the astrocytic involvement in ALS extends beyond this single pathway [72, 78]. The gene discussed is NFKB1; the disease is amyotrophic lateral sclerosis.